The coronavirus disease COVID-19 is a public health emergency caused by a novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS …
H Amirfakhryan - Hellenic Journal of Cardiology, 2021 - Elsevier
Since the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has emerged from China, the infection (novel corona virus disease-2019, COVID-19) has affected many …
E Coto, P Avanzas, J Gómez - European Cardiology Review, 2021 - ncbi.nlm.nih.gov
The renin–aldosterone–angiotensin system (RAAS) plays an important role in the pathogenesis of coronavirus disease 2019 (COVID-19), which is caused by the severe acute …
DJ Kurz, FR Eberli - Swiss Medical Weekly, 2020 - smw.ch
Summary Coronavirus disease 2019 (COVID-19) is primarily a pulmonary disease, but also affects the cardiovascular system in multiple ways. In this review, we will summarise and put …
Mortality from coronavirus disease 2019 (COVID-19) is strongly associated with cardiovascular disease, diabetes, and hypertension. These disorders share underlying …
FP Cappuccio, A Siani - Nutrition, Metabolism and Cardiovascular …, 2020 - Elsevier
The presence of cardiovascular co-morbidities and the known effects of coronaviruses on the cardiovascular system have called attention to the potential implications for patients with …
N Li, L Zhu, L Sun, G Shao - Stem cell research, 2021 - Elsevier
COVID-19 caused by a novel coronavirus named SARS-CoV-2, can elites severe acute respiratory syndrome, severe lung injury, cardiac injury, and even death and became a …
Coronavirus disease 2019 (COVID-19) is usually more severe and associated with worst outcomes in individuals with pre-existing cardiovascular pathologies, including hypertension …
J Guo, Z Huang, L Lin, J Lv - Journal of the American Heart …, 2020 - Am Heart Assoc
According to available clinical data,≈ 15% to 30% of the COVID-19 patients are with hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …